Jakob Ribbing
Jakob Ribbing
Unknown affiliation
Verified email at pharmetheus.com
Title
Cited by
Cited by
Year
Perl-speaks-NONMEM (PsN)—a Perl module for NONMEM related programming
L Lindbom, J Ribbing, EN Jonsson
Computer methods and programs in biomedicine 75 (2), 85-94, 2004
5722004
Perl-speaks-NONMEM (PsN)—a Perl module for NONMEM related programming
L Lindbom, J Ribbing, EN Jonsson
Computer methods and programs in biomedicine 75 (2), 85-94, 2004
5722004
Power, selection bias and predictive performance of the Population Pharmacokinetic Covariate Model
J Ribbing, EN Jonsson
Journal of pharmacokinetics and pharmacodynamics 31 (2), 109-134, 2004
1472004
The lasso—a novel method for predictive covariate model building in nonlinear mixed effects models
J Ribbing, J Nyberg, O Caster, EN Jonsson
Journal of pharmacokinetics and pharmacodynamics 34 (4), 485-517, 2007
652007
A Model for Glucose, Insulin, and Beta‐Cell Dynamics in Subjects With Insulin Resistance and Patients With Type 2 Diabetes
J Ribbing, B Hamrén, MK Svensson, MO Karlsson
The Journal of Clinical Pharmacology 50 (8), 861-872, 2010
362010
A pharmacokinetic comparison of anrukinzumab, an anti‐IL‐13 monoclonal antibody, among healthy volunteers, asthma and ulcerative colitis patients
F Hua, J Ribbing, W Reinisch, F Cataldi, S Martin
British journal of clinical pharmacology 80 (1), 101-109, 2015
272015
Placebo effect model in asthma clinical studies: longitudinal meta-analysis of forced expiratory volume in 1 second
X Wang, D Shang, J Ribbing, Y Ren, C Deng, T Zhou, F Guo, W Lu
European journal of clinical pharmacology 68 (8), 1157-1166, 2012
152012
Longitudinal FEV1 dose–response model for inhaled PF-00610355 and salmeterol in patients with chronic obstructive pulmonary disease
JC Nielsen, MM Hutmacher, A Cleton, SW Martin, J Ribbing
Journal of pharmacokinetics and pharmacodynamics 39 (6), 619-634, 2012
122012
Characterizing Systemic Exposure of Inhaled Drugs: Application to the Long-Acting β2-Agonist PF-00610355
PM Diderichsen, E Cox, SW Martin, A Cleton, J Ribbing
Clinical pharmacokinetics 52 (6), 443-452, 2013
112013
A model‐based longitudinal meta‐analysis of FEV1 in randomized COPD trials
J Korell, SW Martin, MO Karlsson, J Ribbing
Clinical Pharmacology & Therapeutics 99 (3), 315-324, 2016
102016
Predicted heart rate effect of inhaled PF‐00610355, a long acting β‐adrenoceptor agonist, in volunteers and patients with chronic obstructive pulmonary disease
PM Diderichsen, E Cox, SW Martin, A Cleton, J Ribbing
British journal of clinical pharmacology 76 (5), 752-762, 2013
92013
Translating Pharmacometrics to a Pharmacoeconomic Model of COPD
JF Slejko, RJ Willke, J Ribbing, P Milligan
Value in Health 19 (8), 1026-1032, 2016
72016
Assessing the therapeutic benefit of a new inhaled QD LABA through population PK-safety & efficacy modelling
J Ribbing, GL Li, E Van Schaick, L Harnisch
ERS, Vienna, Austria, 2009
42009
Non-Bayesian knowledge propagation using model-based analysis of data from multiple clinical studies
J Ribbing, AC Hooker, EN Jonsson
Journal of pharmacokinetics and pharmacodynamics 35 (1), 117-137, 2008
42008
Covariate Model Building in Nonlinear Mixed Effects Models
J Ribbing
Acta Universitatis Upsaliensis, 2007
42007
A phase II, randomised, placebo controlled trial of 12 weeks treatment with an oral p38 inhibitor in patients with COPD on a background of ICS/LABA
R Fogel, K Shields, J Christensen, J Ribbing, G Langdon, ...
European Respiratory Journal 42 (Suppl 57), 186, 2013
32013
Cross Model Validation As A Tool For Population Pharmacokinetic/Pharmacodynamic Covariate Model Building
J Ribbing, EN Jonsson
PAGE 10 (2001), 2001
32001
Predicting Reductions in Chronic Obstructive Pulmonary Disease (COPD) Exacerbations from FEV1–A Model-Based Meta-Analysis of Literature Data from Controlled Randomized Clinical …
J Ribbing, J Korell, F Cerasoli, PA Milligan, SW Martin, MO Karlsson
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS 42, S63-S63, 2015
2015
Incorporating a pharmacometric model-based meta-analysis into a health economic microsimulation model of COPD
JF Slejko, J Ribbing, RJ Willke
Value in Health 17 (3), A192, 2014
2014
Oral Presentation: Literature Model for FEV1 in COPD Trials – Separating the Dynamic Components of Placebo Effect, Disease Progression and Interacting Drug Effects
J Ribbing, C Falcoz, I Correa, SW Martin
PAGE 21 (2012), 2012
2012
The system can't perform the operation now. Try again later.
Articles 1–20